BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 11344227)

  • 1. Angiotensin-I converting enzyme genotype-dependent benefit from hormone replacement therapy in isometric muscle strength and bone mineral density.
    Woods D; Onambele G; Woledge R; Skelton D; Bruce S; Humphries SE; Montgomery H
    J Clin Endocrinol Metab; 2001 May; 86(5):2200-4. PubMed ID: 11344227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin-converting enzyme gene polymorphism, lipids, and apolipoproteins in menopausal women on hormone replacement therapy.
    Cubrilo-Turek M; Sertić J; Duraković Z
    Acta Med Croatica; 2001; 55(4-5):161-7. PubMed ID: 12398019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ACE ID genotype and the muscle strength and size response to unilateral resistance training.
    Pescatello LS; Kostek MA; Gordish-Dressman H; Thompson PD; Seip RL; Price TB; Angelopoulos TJ; Clarkson PM; Gordon PM; Moyna NM; Visich PS; Zoeller RF; Devaney JM; Hoffman EP
    Med Sci Sports Exerc; 2006 Jun; 38(6):1074-81. PubMed ID: 16775548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin-converting enzyme genotype affects the response of human skeletal muscle to functional overload.
    Folland J; Leach B; Little T; Hawker K; Myerson S; Montgomery H; Jones D
    Exp Physiol; 2000 Sep; 85(5):575-9. PubMed ID: 11038409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of hormone replacement therapy on serum angiotensin-converting enzyme activity and plasma bradykinin in postmenopausal women according to angiotensin-converting enzyme-genotype.
    Sumino H; Ichikawa S; Ohyama Y; Nakamura T; Kanda T; Sakamoto H; Sakamaki T; Mizunuma H; Kurabayashi M
    Hypertens Res; 2003 Jan; 26(1):53-8. PubMed ID: 12661913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hormone replacement therapy increases isometric muscle strength of adductor pollicis in post-menopausal women.
    Skelton DA; Phillips SK; Bruce SA; Naylor CH; Woledge RC
    Clin Sci (Lond); 1999 Apr; 96(4):357-64. PubMed ID: 10087242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The protective effect of hormone-replacement therapy on fracture risk is modulated by estrogen receptor alpha genotype in early postmenopausal women.
    Salmén T; Heikkinen AM; Mahonen A; Kröger H; Komulainen M; Saarikoski S; Honkanen R; Mäenpää PH
    J Bone Miner Res; 2000 Dec; 15(12):2479-86. PubMed ID: 11127213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The predictive value of biochemical markers of bone turnover for bone mineral density in early postmenopausal women treated with hormone replacement or calcium supplementation.
    Rosen CJ; Chesnut CH; Mallinak NJ
    J Clin Endocrinol Metab; 1997 Jun; 82(6):1904-10. PubMed ID: 9177404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-6-174G/C genotype is associated with the bone mineral density response to oestrogen replacement therapy in post-menopausal women.
    James L; Onambele G; Woledge R; Skelton D; Woods D; Eleftheriou K; Hawe E; Humphries SE; Haddad F; Montgomery H
    Eur J Appl Physiol; 2004 Jun; 92(1-2):227-30. PubMed ID: 15083368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation of androgen receptor gene polymorphism to bone mineral density and fracture risk in early postmenopausal women during a 5-year randomized hormone replacement therapy trial.
    Salmén T; Heikkinen AM; Mahonen A; Kröger H; Komulainen M; Pallonen H; Saarikoski S; Honkanen R; Mäenpää PH
    J Bone Miner Res; 2003 Feb; 18(2):319-24. PubMed ID: 12568409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A common methylenetetrahydrofolate reductase (C677T) polymorphism is associated with low bone mineral density and increased fracture incidence after menopause: longitudinal data from the Danish osteoporosis prevention study.
    Abrahamsen B; Madsen JS; Tofteng CL; Stilgren L; Bladbjerg EM; Kristensen SR; Brixen K; Mosekilde L
    J Bone Miner Res; 2003 Apr; 18(4):723-9. PubMed ID: 12674333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ACE-DD genotype is associated with the occurrence of acute coronary syndrome in postmenopausal women.
    Méthot J; Hamelin BA; Bogaty P; Arsenault M; Plante S; Poirier P
    Int J Cardiol; 2005 Dec; 105(3):308-14. PubMed ID: 16274774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of ACE I/D polymorphism and aerobic training on the immune-endocrine network and cardiovascular parameters of postmenopausal women.
    Izzicupo P; Ghinassi B; D'Amico MA; Di Blasio A; Gesi M; Napolitano G; Gallina S; Di Baldassarre A
    J Clin Endocrinol Metab; 2013 Oct; 98(10):4187-94. PubMed ID: 23966242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction between angiotensin converting enzyme insertion/deletion genotype and exercise training on knee extensor strength in older individuals.
    Giaccaglia V; Nicklas B; Kritchevsky S; Mychalecky J; Messier S; Bleecker E; Pahor M
    Int J Sports Med; 2008 Jan; 29(1):40-4. PubMed ID: 17614015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating angiotensin converting enzyme activity is correlated with muscle strength.
    Williams AG; Day SH; Folland JP; Gohlke P; Dhamrait S; Montgomery HE
    Med Sci Sports Exerc; 2005 Jun; 37(6):944-8. PubMed ID: 15947718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ACE ID genotype affects blood creatine kinase response to eccentric exercise.
    Yamin C; Amir O; Sagiv M; Attias E; Meckel Y; Eynon N; Sagiv M; Amir RE
    J Appl Physiol (1985); 2007 Dec; 103(6):2057-61. PubMed ID: 17885020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The angiotensin-converting enzyme insertion/deletion polymorphism and serum levels of angiotensin-converting enzyme in venous thromboembolism. Data from a case control study.
    Ay C; Bencur P; Vormittag R; Sailer T; Jungbauer C; Vukovich T; Mannhalter C; Pabinger I
    Thromb Haemost; 2007 Oct; 98(4):777-82. PubMed ID: 17938801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Additive effects of weight-bearing exercise and estrogen on bone mineral density in older women.
    Kohrt WM; Snead DB; Slatopolsky E; Birge SJ
    J Bone Miner Res; 1995 Sep; 10(9):1303-11. PubMed ID: 7502701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early postmenopausal bone loss is associated with PvuII estrogen receptor gene polymorphism in Finnish women: effect of hormone replacement therapy.
    Salmén T; Heikkinen AM; Mahonen A; Kröger H; Komulainen M; Saarikoski S; Honkanen R; Mäenpää PH
    J Bone Miner Res; 2000 Feb; 15(2):315-21. PubMed ID: 10703934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of early postmenopausal women with no bone response to HRT: results of a five-year clinical trial.
    Komulainen M; Kröger H; Tuppurainen MT; Heikkinen AM; Honkanen R; Saarikoski S
    Osteoporos Int; 2000; 11(3):211-8. PubMed ID: 10824236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.